Genesco GCO Portfolio Impact Q1 2026 Profit Exceeds Views uniQure NV QURE Stock Outlook Q4 2025 Profit Exceeds Views Global GWRS Stock Trending Up Breakout Watch 20260418 NRXP NRX Pharmaceuticals Inc posts wider than expected Q4 2025 loss even as shares rise modestly today Theravance Biopharma TBPH Q1 2026 Earnings EPS 003 Beats Estimates Japans Green Bond Strategy Targets EV Batteries and Emerging Technology Sectors NAVI Q1 2026 Earnings EPS Surprises to the Upside Amid Quiet Quarter Thomson TRI Q1 2026 Earnings EPS 123 Beats Estimates Foreign Investors Offload Over Rs 30000 Crore in Indian Equities in May as 2026 Outflows Reach Rs 222 Lakh Crore International Students Face Growing Hurdles in US Job Market Undermining American Dream Amadeus Fire AG Shareholders Overwhelmingly Approve All Agenda Items Including New Authorised Capital 2026 Baird Raises Price Target on RideNow Group Following Strong SameStore Sales Performance SPIC Reports Higher Q4 Profit on Improved Cost Management FullYear Net Income Rises Retailers Navigate KShaped Economy with Dual Strategies of Price Cuts and Premium Offerings GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues NMFC Q1 2026 Earnings Narrowly Misses EPS Estimates Amid Stable Operations VMD Q1 2026 Earnings EPS Misses Estimates by 34 Amid Uncertain Revenue Outlook BLKB Q1 2026 Earnings Slight EPS Beat Amidst Modest Stock Gains Brixmor Property Group Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength SOHOB Q2 2025 Earnings Preferred Stock Reports EPS of 021 Amid Flat Trading ServiceTitan TTAN Gains 3 as Stock Approaches Key Resistance Level Hennessy Advisors Inc HNNA Rallies 2 as Volume Picks Up Kewaunee Scientific Holds Steady at 3997 Key Support and Resistance Levels in Focus Kronos Worldwide KRO Holds Steady Near 681 as Support and Resistance Levels Come into Focus Skye Bioscience Surges 77 Biotech Stock Tests Resistance at 081 Taiwan Chip Stocks Rally Following Nvidias 150 Billion Capital Expenditure Announcement Cadre Holdings Inc CDRE Q1 2026 Earnings EPS Misses Estimates by 417 Amid Revenue Unavailability Estrella Immunopharma Warrant ESLAW Surges 1885 to 010 Faces Key Resistance at 011